Impact of obstructive sleep apnoea on clinical characteristics and outcomes in patients with acute coronary syndrome following percutaneous coronary intervention

Journal of International Medical Research

Volumn 37, Issue 5, 2009, Pages 1343-1353

  Meng, S ^a   Fang, L ^b   Wang, C Q ^a   Wang, L S ^a   Chen, M T ^a   Huang, X H ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Acute coronary syndrome; C Reactive protein; Major adverse cardiac events; Obstructive sleep apnoea syndrome; Percutaneous coronary intervention

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CAROTID ARTERY; ECHOGRAPHY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAROTID ARTERIES; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 77649202035     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/147323000903700509     Document Type: Article

References (37)

1. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
2. Levinson PD, McGarvey ST, Carlisle CC, et al: Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 1993; 103: 1336-1342.
3. Ancoli-Israel S, Coy T: Are breathing disturbances in elderly equivalent to sleep apnea syndrome? Sleep 1994; 17: 77-83.
4. Malone S, Liu PP, Holloway R, et al: Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338: 1480-1484.
5. Hung J, Whitford EG, Parsons RW, et al: Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336: 261-264.
6. Guilleminault C, Connolly SJ, Winkle RA: Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490-494.
7. Palomaki H, Partinen M, Erkinjuntti T, et al: Snoring, sleep apnea syndrome, and stroke. Neurology 1992; 42: 75-81.
8. Nieto FJ, Young TB, Lind BK, et al for the Sleep Heart Health Study: Association of sleep- disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283: 1829-1836.
9. Weitzenblum E, Krieger J, Apprill M, et al: Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988; 138: 45-49.
10. Wang HY, Gao PJ, Ji KD, et al: Circulating endothelial progenitor cells, C-reactive protein and severity of coronary stenosis in Chinese patients with coronary artery disease. Hypertens Res 2007; 30: 133-141.
11. Suzuki T, Nakano H, Maekawa J, et al: Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 2004; 27: 129-133.
12. Sahn DJ, DeMaria A, Kisslo J, et al: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
13. Young T, Palta M, Dempsey J, et al: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
14. Schafer H, Koehler U, Ewig S, et al: Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999; 92: 79-84.
15. de Sousa AG, Cercato C, Mancini MC, et al: Obesity and obstructive sleep apnea-hypopnea syndrome. Obes Rev 2008; 9: 340-354.
16. Hanly P, Sasson Z, Zuberi N, et al: ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 1993; 71: 1341-1345.
17. Yokoe T, Minoguchi K, Matsuo H, et al: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-1134.
18. Ryan S, McNicholas WT: Inflammatory cardiovascular risk markers in obstructive sleep apnoea syndrome. Cardiovasc Hematol Agents Med Chem 2009; 7: 76-81.
19. El-Solh AA, Mador MJ, Sikka P, et al: Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002; 121: 1541-1547.
20. Chin K, Nakamura T, Shimizu K, et al: Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000; 109: 562-567.
21. Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939.
22. Ryan S, McNicholas WT: Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. Arch Physiol Biochem 2008; 114: 261-266.
23. Hedner J, Ejnell H, Caidahl K: Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990; 8: 941-946.
24. Usui K, Parker JD, Newton GE, et al: Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am J Respir Crit Care Med 2006; 173: 1170-1175.
25. Tkacova R, Rankin F, Fitzgerald FS, et al: Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998; 98: 2269-2275.
26. Noda A, Okada T, Yasuma F, et al: Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995; 107: 1538-1544.
27. Young T, Skatrud J, Peppard PE: Risk factors for obstructive sleep apnea in adults. JAMA 2004; 291: 2013-2016.
28. Steiner S, Jax T, Evers S, et al: Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 2005; 104: 92-96.
29. von Kanel R, Dimsdale JE: Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003; 124: 1956-1967.
30. Yumino D, Tsurumi Y, Takagi A, et al: Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 2007; 99: 26-30.
31. Peker Y, Hedner J, Kraiczi H, et al: Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81-86
32. Mooe T, Franklin KA, Holmstrom K, et al: Sleep- disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001; 164: 1910-1913.
33. Kripke DF, Ancoli-Israel S, Klauber MR, et al: Prevalence of sleep-disordered breathing in ages 40-64 years: a population-based survey. Sleep 1997; 20: 65-76.
34. Kajaste S, Brander PE, Telakivi T, et al: A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004; 5: 125-131.
35. Li KK, Kushida C, Powell NB, et al: Obstructive sleep apnea syndrome: a comparison between Far-East Asian and white men. Laryngoscope 2000; 110: 1689-1693.
36. Phillips BG, Kato M, Narkiewicz K, et al: Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000; 279: H234-H237.
37. Harsch IA, Konturek PC, Koebnick C, et al: Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003; 22: 251-257.